- Home
- ABOS vs APYX Comparison
ABOS vs APYX Comparison
Compare ABOS & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- APYX
- Stock Information
- Founded
- ABOS 1996
- APYX 1982
- Country
- ABOS United States
- APYX United States
- Employees
- ABOS N/A
- APYX N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- ABOS Health Care
- APYX Health Care
- Exchange
- ABOS Nasdaq
- APYX Nasdaq
- Market Cap
- ABOS 76.9M
- APYX 61.7M
- IPO Year
- ABOS 2021
- APYX 1987
- Fundamental
- Price
- ABOS $1.08
- APYX $1.23
- Analyst Decision
- ABOS Strong Buy
- APYX Hold
- Analyst Count
- ABOS 3
- APYX 2
- Target Price
- ABOS $7.33
- APYX N/A
- AVG Volume (30 Days)
- ABOS 206.3K
- APYX 52.3K
- Earning Date
- ABOS 03-27-2025
- APYX 03-13-2025
- Dividend Yield
- ABOS N/A
- APYX N/A
- EPS Growth
- ABOS N/A
- APYX N/A
- EPS
- ABOS N/A
- APYX N/A
- Revenue
- ABOS N/A
- APYX $48,102,000.00
- Revenue This Year
- ABOS N/A
- APYX $2.76
- Revenue Next Year
- ABOS N/A
- APYX $7.34
- P/E Ratio
- ABOS N/A
- APYX N/A
- Revenue Growth
- ABOS N/A
- APYX N/A
- 52 Week Low
- ABOS $1.05
- APYX $0.93
- 52 Week High
- ABOS $4.06
- APYX $1.99
- Technical
- Relative Strength Index (RSI)
- ABOS 34.99
- APYX 47.47
- Support Level
- ABOS $1.14
- APYX $0.93
- Resistance Level
- ABOS $1.28
- APYX $1.43
- Average True Range (ATR)
- ABOS 0.10
- APYX 0.13
- MACD
- ABOS -0.01
- APYX 0.02
- Stochastic Oscillator
- ABOS 6.98
- APYX 58.58
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.